Table 1 Clinical material and efficacy of the 45 patients
Characters | NO. | CR, n (%) | PR, n (%) | SD, n(%) | PD, n (%) |
|---|---|---|---|---|---|
Gender | Â | Â | Â | Â | Â |
   Male | 19 | 0 | 15.8(3) | 36.8(7) | 47.4(9) |
   Female | 26 | 0 | 46.1(12) | 38.5(10) | 15.4(4) |
Age(year) | Â | Â | Â | Â | Â |
   < 70 | 35 | 0 | 34.3(12) | 37.1(13) | 28.6(10) |
   ≥70 | 10 | 0 | 30.0(3) | 40.0(4) | 30.0(3) |
Smoking status | Â | Â | Â | Â | Â |
   Smokers | 17 | 0 | 17.6(3) | 41.2(7) | 41.2(7) |
   Non-smokers | 28 | 0 | 42.9(12) | 35.7(10) | 21.4(6) |
Tumor histology | Â | Â | Â | Â | Â |
   Adeno. | 26 | 0 | 38.5(10) | 42.3(11) | 19.2(5) |
   BAC | 4 | 0 | 75.0(3) | 25.0(1) | 0.0(0) |
Squamous | 10 | 0 | 10.0(1) | 30.0(3) | 60.0(6) |
   Adenosquamous | 5 | 0 | 20.0(1) | 40.0(2) | 40.0(2) |
Stage | Â | Â | Â | Â | Â |
   IIIb | 14 | 0 | 28.6(4) | 50.0(7) | 21.4(3) |
   IV | 31 | 0 | 35.4(11) | 32.3(10) | 32.3(10) |
Brain metastasis | 4 | 0 | 75.0(3) | 25.0(1) | 0.0(0) |
PS value | Â | Â | Â | Â | Â |
   ≤ 2 | 32 | 0 | 37.5(12) | 37.5(12) | 25.0(8) |
   3~4 | 13 | 0 | 23.0(3) | 38.5(5) | 38.5(5) |